Expert Roundtable Recommendations on Wound-Bed Optimization in Difficult-to-Heal Wounds: Clinical Positioning of ON101 From a U.S. Multidisciplinary Roundtable

多学科方法 医学 统计学家 报销 伤口闭合 多学科团队 重症监护医学 糖尿病足 梅德林 临床实习 结束语(心理学) 循证医学 临床试验 医学教育 工程伦理学 医学物理学 管理科学 循证实践 成果研究 系统回顾 小组讨论 临床研究 临床决策
作者
John C Lantis,Michael N Desvigne,Laura Pfendler,Mark D Suski,Greg Bohn,Zwelithini Tunyiswa,Mervin Low,Abigail E. Chaffin,Brock A. Liden
出处
期刊:Chronic Wound Care Management and Research [Dove Medical Press]
卷期号:1 (1)
标识
DOI:10.67702/svjn5233
摘要

Diabetic foot ulcers (DFUs) remain a major clinical and economic challenge and may persist within a dysregulated wound microenvironment characterized by persistent inflammation, impaired cellular signaling, microbial biofilm burden, and failure to progress through normal healing pathways. ON101 is a provider- directed topical wound-bed optimization matrix developed to support progression toward closure in difficult-to-heal DFUs. To review the available evidence and develop structured expert roundtable recommendations regarding the role of ON101 as an adjunctive wound-bed optimization approach for difficult-to-heal DFUs. Potential applications beyond DFUs were considered separately as emerging research contexts. Discussion focused on patient selection, treatment timing, integration with standard care, administration, implementation, economic considerations, and research priorities. Methods: A multidisciplinary structured expert roundtable was convened in April 2026 in Charlotte, North Carolina, involving 11 panelists, including 10 clinical experts and one wound-care research statistician and healthcare/research executive, representing wound care, surgery, podiatry, and related clinical specialties. Panel members reviewed preclinical, clinical, real-world, health-economic, regulatory, and emerging evidence and discussed key questions regarding integration of ON101 into wound management. Draft statements were developed from discussion themes and areas of broad agreement and reviewed by participants. No formal voting or prespecified agreement threshold was used, and the recommendations should not be interpreted as formal clinical practice guidelines. Results: The panel identified difficult-to-heal wounds characterized by persistent inflammation, biofilm burden, delayed closure progression, and wound microenvironment dysfunction as clinical features of interest for ON101 consideration, while recognizing that predictors of differential treatment response have not been established. Emphasis was placed on difficult-to-heal DFUs, where the strongest evidence currently exists. In physician-directed DFU care, early wound-area reduction at four weeks may serve as a prognostic reassessment marker to identify wounds requiring continued optimization or escalation; it does not establish the optimal timing of ON101 initiation. Preliminary U.S. real-world evidence reported greater early wound-area reduction, shorter time to complete closure and lower direct cost per wound with ON101 compared with matched standard-care controls; these findings are hypothesis-generating. The panel conditionally supported consideration of ON101 during active wound-bed optimization, although optimal timing has not been prospectively established. Roundtable recommendations emphasized that ON101 should be integrated with established standards of care, including etiology-appropriate wound-bed preparation, infection and vascular management, offloading or compression as indicated, and systemic optimization. While the strongest evidence currently exists for diabetic foot ulcers, applications in radiation-associated wounds, pressure injuries, venous leg ulcers, post-surgical wounds, and other difficult-to-heal wound types were considered emerging or research-only applications requiring prospective evaluation. Limitations: The recommendations reflect a structured expert roundtable informed by available evidence and clinical experience rather than formal evidence-based guidelines or standards of care. Evidence is strongest in DFUs; evidence in other wound types remains limited or preliminary. Conclusions: The panel concluded that ON101 may be considered as an adjunct to comprehensive wound care, particularly for difficult-to-heal DFUs, during active wound-bed optimization. Priority outcomes for future evaluation include complete closure, time to closure, early wound-area reduction, subsequent interventions, healthcare encounters, and total cost of care. Further research should address comparative effectiveness, patient selection, dosing, biomarkers, implementation, and health-economic outcomes, particularly beyond DFUs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
博慧完成签到 ,获得积分10
刚刚
刚刚
灭法者发布了新的文献求助10
刚刚
彭于晏的应助被我要发Nature采纳,获得10
1秒前
yichen完成签到,获得积分10
1秒前
尘_发布了新的文献求助10
1秒前
hhh完成签到 ,获得积分10
1秒前
英俊的铭的应助被激动的绿竹采纳,获得10
2秒前
3秒前
3秒前
可爱眼神发布了新的文献求助10
3秒前
3秒前
3秒前
MAZE完成签到 ,获得积分10
4秒前
S10完成签到 ,获得积分10
4秒前
想吃泡粉完成签到,获得积分10
4秒前
儒偿所愿发布了新的文献求助10
5秒前
急急急发布了新的文献求助30
5秒前
香蕉觅云的应助被拼搏凝冬采纳,获得10
5秒前
5秒前
6秒前
Nevaeh完成签到,获得积分10
6秒前
qyc发布了新的文献求助10
6秒前
mimimi完成签到,获得积分10
6秒前
6秒前
wow发布了新的文献求助10
7秒前
hyy关注了科研通微信公众号
7秒前
三金完成签到,获得积分10
7秒前
敏感的蚂蚁完成签到 ,获得积分10
7秒前
LEETHEO发布了新的文献求助10
7秒前
desert完成签到 ,获得积分10
7秒前
凯旋侯发布了新的文献求助10
8秒前
犹豫听寒完成签到 ,获得积分10
8秒前
细心的易文完成签到,获得积分10
8秒前
hanjia315完成签到,获得积分10
9秒前
yyf完成签到,获得积分10
9秒前
9秒前
shenwomiss关注了科研通微信公众号
10秒前
zjx发布了新的文献求助30
10秒前
ELF02完成签到,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253